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Abstract
The chapter summarizes available research on polyphenols and the potential 
for polyphenol based therapeutics. Polyphenols have the potential to be used in a 
multi-target fashion therapeutically. The majority of the polyphenol benefits appear 
to share positive effects across multiple disease states including inflammatory 
diseases, diseases of metabolic dysregulation and cancer. The reviewed literature 
includes human, animal and cell culture based studies. Selected mechanisms within 
each disease state are highlighted including interleukin inflammatory markers, 
NF-κB, acetyl-CoA concentration regulation of metabolism, and p-glycoprotein 
multidrug efflux pump associated with cancer treatment failures. Reviewed studies 
discuss polyphenols inhibiting transcription factors that control expression on 
inflammatory factors as well as activating other transcription factors that increase 
expression of enzymes protective of oxidative damage. Levels of metabolic regula-
tory enzymes are also affected positively by polyphenol addition through epigenetic 
modifications. Epigenetic modifications affecting cancer development and progres-
sion appear positively affected by polyphenol treatment. Additionally, oxidative 
damage protection of normal cells can be achieved by polyphenol treatment thus 
limiting chemotherapeutic damage. Upon review of the available literature, a 
strong case for the potential use of polyphenols in therapeutic situations stands out. 
Potential risks included are that the purity and specific concentrations required 
to achieve therapeutic benefits without potential side effects need to be examined 
prior to the adoption of therapeutics.
Keywords: polyphenols, therapy, natural products
1. Introduction
Polyphenols are molecules with multiple hydroxyl groups that have been shown 
to provide numerous health benefits including reduction of inflammation, meta-
bolic control and anti-cancer properties. Polyphenols can be found in a variety of 
natural sources such as cinnamon, green tea, coffee, vegetables and fruits. Although 
some evidence exists for the mechanisms of polyphenol molecules that lead to these 
health benefits, there is still much unknown about how these compounds act to 
alter metabolism, inflammation levels and cancer pathways. Some research suggests 
epigenetic modifications that alter expression level of disease state genes explain 
the benefits, while others identify potential signaling pathway and transcription 
factor targets affected by polyphenols or their metabolites as the method of control. 
One difficulty in researching the potential for polyphenol based therapies is the 
tremendous crossover between pathways that can affect multiple metabolic actions 
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ranging from dysregulation of metabolism to loss of cell cycle control. On top of 
the multi-targeted effects from signaling, epigenetic modifications can be detected 
and identified but not always possible to predict. Although the field of dietary 
therapeutics provides a much needed alternative to many other treatments, the 
uncertainty of use in certain cultures make it a challenging research topic but all the 
more important to tackle.
Some of the most commonly studied polyphenols include the catechin group. 
Available evidence suggests that some forms have higher activity on some targets 
but the active forms differ from target to target. For example, it has been suggested 
that resveratrol, which is a fused ring complex between two catechin molecules, 
binds to and modulates the allosteric effects of Sirt1 thus playing a role in deacety-
lation/acetylation of multiple targets [1–3]. The metabolic regulator FoxO1 is a 
transcription factor that is deacetylated by Sirt1 thus changing metabolic function 
as well as cell death pathways [4]. Modified catechins known as epigallocatechin 
gallate (EGCG) are found in high levels in green tea and have been shown to modify 
the epigenome of MCF7 breast cancer cells [5]. Observed results show multiple 
types of epigenetic modifications including both methylation of the DNA and 
acetylation of histones. Compounds found in cinnamon include polyphenol A, a 
linked dual catechin, which has been studied as a potential insulin mimic com-
pound [5]. Additional compounds found in cinnamon include rutin, an acid labile 
bond between quercetin and epicatechin that have been predicted to interact with 
Sirt1 [1]. Additionally cinnamon has been shown to increase expression of both 
GLUT4 expression and translocation in adipose and muscle, although the respon-
sible component of cinnamon has not been identified with certainty [6, 7].
The collection of evidence suggesting that natural products provide profound 
therapeutic benefits is growing. Although pharmaceutical industries have devel-
oped drugs that are effective at treating symptoms of metabolic dysregulation and 
inflammation, the majority of these medicines are focused on symptom manage-
ment and targeted effects. The spectrum of benefits that are possible with poly-
phenol based therapies offer a potential to treat multiple disease states by targeting 
the root cause of disease. There is still much to be learned about how the effects of 
polyphenols can be predicted and if cross reactivity exists that could benefit one 
disease state but hurt another. However, the likelihood of reciprocal effects of a 
therapeutic is less likely when one known effect is beneficial on a broad scale than if 
the polyphenol therapy were aimed at controlling only one target. As many people 
become concerned about potential side effects of pharmaceuticals, some find 
comfort in alternative medicine such as polyphenols.
2. Effects of inflammation
Recent literature has demonstrated that a growing number of disease states 
result from chronic inflammation [8]. Inflammation is the body’s response to a 
variety of stimuli such as viral or bacterial infection, disease state markers, and 
injury resulting in tissue damage. The body has developed and refined this inflam-
matory response as an immune response to protect the body from damage from 
these stimuli. In general, an individual’s immune response is elicited only as a result 
of the stimulus. This specific response may cause an acute inflammatory response 
of increased inflammatory markers which generally function to protect the body 
for a short period of time, but then return to normal levels. Acute inflammation, 
although potentially serious in some cases, can be expected to alleviate over time. In 
contrast, chronic inflammation is the type of inflammation that is typically associ-
ated with disease states or development of disease. Chronic inflammation is an 
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ongoing, constant and consistent release of inflammatory markers that ultimately 
result in damage to the tissues. In many cases, chronic inflammation results from 
obesity, continuous stress or anxiety, diabetes, and poor sleep. Autoimmune condi-
tions can result from chronic inflammation, or can themselves add to the chronic 
level of inflammatory proteins circulating in the body. Oftentimes this is a whole 
body inflammatory response rather than an isolated location or injury as seen in 
acute inflammation.
2.1 Why is inflammation a health issue?
Although it appears to have taken decades to confirm the involvement of inflam-
mation in disease risk, it seems to be a logical expectation. Inflammatory markers 
in circulation are chemokines that direct the body’s processes. They exist simply to 
allow the body to detect a problem and illicit a response. Inflammation represents 
one of our most innate protective responses. However, it stands to reason that if 
the body detects a damage risk, the response will be elevated. This elevated inflam-
matory marker level itself can result in damage that increases the response further. 
The inflammatory response becomes chronic and continues in a feed forward loop 
continually signaling the body to respond. The effects of this endless response cycle 
result in disease state symptoms that require therapeutic intervention. In a similar 
fashion, tissue damage resulting from chronic inflammation can result in the 
development of diseases of metabolic dysfunction, asthma, cardiovascular disease, 
cancer, arthritis, among others.
It has become more common to exist in a continuous loop of stressors. Some of 
these stressors include: malnutrition, chronic stress, obesity, inactivity, and toxin 
exposure. All of these conditions can lead to chronic inflammation and result in 
further tissue and cell damage. Although a healthy lifestyle can certainly help to 
alleviate these responses, sometimes the disease state itself makes achieving the 
ideal healthy lifestyle nearly impossible. Careful attention to the type of foods 
selected can help decrease the chronic inflammation and break the continuous 
cycle. Certain foods and spices contain high levels of polyphenols which have been 
shown to help mediate the inflammatory process. Visceral obesity in particular can 
increase inflammation and associated markers including reactive oxygen species, 
interleukins 6 and 8, adiponectin and tumor necrosis factor alpha (TNF-α) [9, 10].
2.2 How can polyphenols limit inflammation?
There are several potential ways in which polyphenols can help to moderate the 
inflammation levels: these include targets in the signaling pathways, limitation of 
reactive oxygen species and reactive nitrogen species. Once generated the reaction 
oxygen or nitrogen species can result in reactive organic molecules as well. These 
reactive compounds can cause damage to the cells’ genetic material, lipids found 
throughout the body especially in cell membranes and proteins required for cell 
structure and repair [11, 12].
Polyphenols show considerable potential to regulate oxidative stress and there-
fore inhibit inflammation [13–15]. Reactive oxygen species (ROS) are generated 
readily by metabolic reactions and include hydrogen peroxide, superoxide and 
hydroxyl radicals. These ROS can be particularly troublesome when they interact 
with nitric oxide in the blood vessels because nitrogen reactive species peroxynitrite 
is produced. Similarly, ROS and lipids circulating in the arteries can react to form 
oxidized lipid which can worsen the development of atherosclerosis. Some poly-
phenols, such as flavonoids, have the ability to scavenge superoxide and peroxyni-
trite thus inactivating them and preventing the almost certain cell damage [16]. 
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In addition to inactivating ROS and peroxynitrite, some polyphenols also chelate 
the metal ions required for creation of these reactive species thus inhibiting their 
activation [17].
Several studies have identified signaling protein and transcription factor targets 
that can be affected by polyphenols [18–20]. In many cases the polyphenols target 
multiple proteins within a cascade of responses that can alter not only inflammatory 
response, but also mediate expression of cell death genes and metabolic function. 
Although initially the effect on inflammation will be discussed, there is significant 
overlap in signaling cascades that result in multiple effects.
Available data trends demonstrate that polyphenols are able, in part, to help 
regulate the expression of nuclease factor kappa beta (NF-κβ), a transcription 
factor that is expressed during conditions of oxidative stress [18]. NF-κβ binds to 
DNA when active and functions as a positive transcription factor for a variety of 
pro-inflammatory cytokines. An increase in inflammation can result in increased 
levels of TNF-α, interleukin-6 (IL-6) and enzymes inducible nitric oxide synthase 
and cyclooxygenase 2. Inducible nitric oxidase synthase is responsible for the 
production of the reactive nitrogen peroxynitirite, and cyclooxygenase 2 catalyzes 
the production of prostaglandins. The ability of polyphenols to interact with these 
factors identifies polyphenols as potentially healthful food bioactive that can help 
fight both the results of inflammation as well as the disease that cause inflamma-
tion. Curcumin, a polyphenol found in turmeric root, has been shown to block 
activation of NF-κβ, thus blocking this pathway and excluding NF-κβ from the 
nucleus [18]. Similarly, some polyphenols can decrease NF-κβ activity by directly 
interacting with subunits of the factor [21].
Some polyphenols have been found to activate the transcription factor Nrf2, 
which when expressed at high levels protects the cells from the damaging effects of 
reactive oxygen species and inflammatory markers [20, 22]. Nrf2 is a key inducer of 
protective mechanisms against oxidative stress, leading towards increased produc-
tion of enzymes such as superoxide dismutase, catalase, and glutathione-s transfer-
ases, all of which help to modulate the ROS produced. Polyphenols have been shown 
to increase nuclear translocation of Nrf2, thus allowing increase transcription of the 
oxidative stress protective genes [22].
3. Metabolic effects
3.1 Metabolic dysregulation
The loss of proper metabolic regulation results in a variety of disease states 
including those associated with chronic inflammation mentioned above. Some such 
diseases include obesity, diabetes, hyperlipidemia, and type 2 diabetes. Patients 
that develop a dysregulated metabolism also tend to experience chronic inflam-
mation and vice versa. The two health concerns feed off of each other. Metabolic 
dysregulation historically has been assigned to lifestyle and diet only, but more 
recently consideration of multigenerational epigenetic effects and environmental 
contributions have been included as a cause for the beginning of metabolic dysregu-
lation [23–25]. The days of it being dismissed as caused completely by the patient 
are or should be past. Fetal programming has been adopted as a significant cause of 
metabolic syndrome in offspring that can lead to the development of obesity and 
insulin resistance [26–29].
Many epigenetic modifications lead to changes in metabolic function. One 
such example is acetyl-CoA carboxylase, the enzyme the converts acetyl-CoA into 
malonyl-CoA for entry into the fatty acid synthesis pathway. Galdieri and Vancura 
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have demonstrated that this enzyme aids in regulation of histone acetylation. 
Specifically they have identified that histone acetylation, one major method of 
epigenetic control, depends on acetyl-Co generated prior to entry into the Kreb’s 
cycle that can be limited in conditions where acetyl-CoA carboxylase is expressed 
at higher levels. Interestingly, they noted that the acetyl-CoA required to acetylate 
histones for transcriptional regulation was more readily available when expression 
of acetyl-Co carboxylase was limited [30].
The importance of this acetyl-CoA – histone acetylation connection is that a 
global connection between metabolic activity and the transcriptional control of all 
genes. Any upregulation in the acetyl-CoA carboxylase, which you would expect 
in individuals with excessive glucose intake due to either limited balanced meal 
options or overindulgence in high carbohydrate foods, could potentially be inhibit-
ing their ability to acetylate histones. Additional enzymes that contribute to the 
intercellular concentration of acetyl-CoA, such as ATP citrate lyase have also been 
identified [31]. ATP citrate lyase converts citrate formed in the first step of the 
Kreb’s cycle to acetyl-CoA. Again this further demonstrates how food intake and 
availability can be communicated to cells in such a way that allows gene transcrip-
tion to be silenced or enhanced.
Histone acetylation is catalyzed by histone acetyl transferases (HATs) and 
responsible for reprogramming gene expression along with histone deacetylases 
(HDACs). In general acetylation of histones in a specific gene region will increase 
expression of the gene, while deacetylation (catalyzed by HDACs) decreases gene 
expression of subsequent genes. Polyphenols have been shown to interact consider-
ably with the HAT and HDAC enzymes and therefore have the potential to assist 
with re-regulation of metabolism.
3.2 Polyphenol potential for re-regulation
Numerous studies have demonstrated the potential to reverse, at least partially, 
some of the changes resulting from metabolic dysregulation [32–35]. Reversing 
or alleviating some of the inflammation associated with conditions such as meta-
bolic syndrome may help to mediate the increased risk of cardiovascular disease 
with these conditions. The incidences of cardiovascular disease and diabetes are 
increasing globally and polyphenols offer a natural, inexpensive way to help slow 
the development of the comorbidities associated with these disease states. In most 
cases the effectiveness of the polyphenol treatment comes from its effects on insulin 
resistance and inflammatory reduction [32, 33, 36]. Although there seems to be 
significant effects on improving health with the use of dietary polyphenols, the 
more comorbidities a patient suffers from, the more unlikely it will benefit them to 
the extent necessary. For this reason, it is important that patients hoping to achieve 
results from polyphenol consumption begin polyphenol therapy at the first sign 
of metabolic dysregulation or perhaps even better, begin using polyphenols as a 
preventative measure. Few studies have been conducted that look at polyphenol 
use as an adjunctive therapy for metabolic conditions, but rather as a potential sole 
therapy. Similarly, the effectiveness of polyphenol therapy alone show strong ties to 
specific populations [34].
As discussed previously, availability of acetyl-CoA is controlled by metabolic 
enzymes and dietary input. Levels of acetyl-CoA also affect histone acetylation 
which can control transcription of a variety of genes. A proposed link of HAT 
activity to diabetes exists because of the interaction between the HAT, glucokinase 
and hepatocyte nuclear factor that relates to a transcriptional change rather than 
a true epigenetic change [35]. The transcriptional changes come from the increase 
in acetylation marks present because of the HAT activity that interacts with the 
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gene promoter for pro-inflammation gene products that depend also on NF-κβ for 
expression [35]. This example demonstrates yet another link between diseases of 
metabolic dysregulation and those of inflammation or cancer.
In terms of therapeutic potential of polyphenol for metabolic dysregulation, it 
seems that enhancing acetylation of histones is not the only benefit of consump-
tion. Polyphenols, particularly those found in cinnamon, improve insulin resistance 
and improve lipid profile [32, 33, 37, 38]. Some clinical studies have demonstrated 
reductions of 12.9–52.2 mg/dL in blood glucose levels while others have found less 
robust and potentially null effects [38–40].
4. Cancer prevention possibilities
Polyphenols likely have many different mechanisms of how they can prevent 
proliferation and overall survival of cancerous cells. As mentioned in previous 
sections, there is substantial overlap among mechanisms. Due to this overlap, it is 
almost certain that multiple mechanisms are involved to provide the cancer preven-
tion properties of polyphenols. It is therefore more convenient to present research 
based on some of the individual actions of polyphenols such as anti-oxidative 
properties, pro-oxidant activity, mediation of cellular signaling, and epigenetic 
modifications [41].
4.1 Antioxidant properties
The structure of polyphenols makes them great antioxidants due to the high 
availability of hydroxyl groups attached. The more hydroxyl groups present on the 
molecule, the greater the potential for antioxidant activity [41]. Cancer cells have 
been shown to increase greater amounts of reactive oxygen species (ROS) than 
non-cancerous cells. Through various different pathways, ROS have been shown 
to promote both tumorigenesis and the proliferation through mechanisms such 
as angiogenesis and the promotion of cell migration [42]. Flavonoids have been 
shown to lower the amount of ROS by scavenging free radicals, chelating of transi-
tion metals that help form further ROS, and regulating oxidative stress-mediated 
enzyme activity [43]. Research has shown that rats treated with epigallocatechin 
gallate (EGCG) had increased levels of antioxidant enzymes [44]. Lowering 
ROS levels results in the prevention of cancerous cells to undergo proliferation or 
migration.
4.2 Pro-oxidant activity
Effectiveness of cancer treatment can also be improved by modulating oxida-
tive levels in the cells. Oxidative stress can damage cells and cancer cells have an 
increased capacity to handle oxidative damage. Taking advantage of this increased 
capacity, cancer cells can somewhat be recognized more specifically. Therapies 
involving polyphenols generally reduce oxidative damage, but in cancer cells the 
standard signaling is already modified, thus some polyphenols actually increase 
oxidative damage to a level in which apoptosis and therapeutic sensitivity increased. 
Research shows that cancer cells undergo changes to better handle the high levels of 
ROS in their environment such as generating higher levels of nicotinamide adenine 
dinucleotide phosphate (NADPH) [45–47]. This better equips cancerous cells to 
resist the effects of oxidative stress that can lead to apoptosis. However, this resis-
tance is still able to be overcome by increasing the amount of ROS to a level more 
than the cells can handle.
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Many polyphenols have been shown in vitro to have pro-oxidant activity by 
utilizing transition metals already present in biological systems to create more ROS 
and overcome the natural resistance that cancerous cells possess [48–50]. Vitamin C 
has been shown in high doses to inhibit tumor growth as well as metastasis without 
harming non-cancerous cells present. Ascorbate as a standalone treatment has 
been shown to reduce both tumor growth and weight by 41–53% in Ovcar5, Pan02, 
and 9 L tumors. It was also shown to reduce the amount of metastases that were 
present in approximately 30% of 9 L glioblastoma control groups [51]. This shows 
promise, as a difficulty surrounding cancer treatment is the incidental harm of 
non-cancerous cells simultaneous to cancerous cells. Potentially utilizing natural 
polyphenols already present in biological systems may be a way to work around this 
issue. Another class of polyphenols, hydroxycinnamic acids, has shown the ability 
to damage DNA molecules in the presence of Cu(II) ions [52]. Further studies are 
crucial in determining the in vivo ability of polyphenols to replicate results shown 
in vitro.
4.3 Mediation of cellular signaling
As mentioned in both the inflammation and metabolism sections, NF-κβ is an 
important component in the inflammatory nature of cancerous cells. It is believed 
that it is the primary factor responsible for inducing a variety of cancer molecules 
such as adhesion molecules, growth factors, angiogenic proteins, cell prolifera-
tion proteins and inflammatory cytokines [41]. NF-κβ also increases expression of 
inhibitors of apoptosis and suppresses the expression of genes involved in cell death 
[53]. Research has shown that polyphenols have the ability to interfere with NF-κβ’s 
mechanisms specifically involved with cancer. Flavonoids disrupt inhibitors of 
kappa kinase (IKK), an activator of NF-κβ, as well as binding directly to NF-κB and 
preventing its binding to DNA [41, 54, 55]. The mediation of polyphenols in these 
pathways can provide valuable anti-inflammatory benefits that can both prevent 
the formation of cancerous cells and tumors, as well as removing the suppression of 
apoptosis that is caused by NF-κβ leading to cell death.
4.4 Epigenetic modifications
Methylation of specific cancer genes has become a key predictor of both mark-
ers of cancer and cancer survival. One example of this is the methylation state 
of the BRCA1 promoter gene in ovarian cancer. Research showed that patients 
with a higher level of methylation on the gene, had a shorter median for disease 
free interval. It also showed that facilitating demethylation of the gene results in 
increased survival time and decreased occurrence rate [41, 56]. DNA methyltrans-
ferase (DNMT) is the enzyme responsible for methylation of genes. Polyphenols 
have been shown to decrease methylation by inhibiting DNMT. In vitro, DNMT was 
inhibited by EGCG at a concentration of 20 μmol/L [57]. The ability for polyphenols 
to inhibit DNMT and other methyltransferase enzymes makes them of interest for 
not only cancer prevention, but other disease states that are affected by an increase 
in methylation of DNA [41]. Research in this area should continue so a greater 
understanding of the ability for polyphenols to affect methyltransferase enzymes 
such as DNMT.
4.5 Cancer treatment adjunctive therapy
Cancer therapies are an ever changing area of interest as we better understand 
ways to induce cancer cell death as well as maintain the health of non-cancerous 
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cells in the body. Resistance to chemotherapies is also an area of concern making 
it difficult to achieve appropriate therapy and leading to more aggressive treat-
ments which leads to an increase in harm to non-cancerous cells. One of the ways 
that cancer cells present resistance is in the increase of the multidrug resistant 
p-glycoprotein transporter. The p-glycoprotein transporter pumps the drugs out 
of the therapeutic intracellular location. Curcumin has been shown to suppress 
the action of the multidrug resistant p-glycoprotein transporter. Sulfasalazine, a 
specific substrate for the multidrug resistance protein ABCG2, was shown to have 
an increased Cmax concentration in the presence of a 400 mg/kg dose in mice. The 
change was 1230 ng/mL in the absence of curcumin and 3350 ng/mL with curcumin 
present [58]. This would in turn result in an increase in concentration of medication 
inside the cancer cell and therefore greater efficacy of the therapy making curcumin 
a good possibility for adjuvant therapy. Another issue arises during chemotherapy 
in the possible need to increase ROS to produce apoptosis of cancerous cells [59]. 
These ROS also negatively affect non-cancerous cells so the need to protect these 
cells is crucial to ensure appropriate chemotherapy can continue. As mentioned 
above, one of the mechanisms in how polyphenols can prevent cancer is through 
their antioxidant activity. Through this mechanism, polyphenols can provide valu-
able adjuvant therapy for patients allowing them to prolong their chemotherapy 
without increasing negative effects associated with the increase in ROS.
5. Conclusion
The potential for polyphenols to be used therapeutically appears more probable 
as more research is completed. Additionally, the benefits likely cross into multiple 
disease states with positive effects for them all. Pro-inflammatory transcription 
factor NF-κβ is inhibited by binding of polyphenols, thus limiting the expression 
of harmful inflammatory factors. Similarly, NF-κβ activity can also be blocked 
by limiting its activation via the signaling pathway. While limiting NF-κβ activity 
limits inflammation, activating the positive transcription factor Nrf2 increases 
expression of enzymes protective of oxidative damage. Studies demonstrate that 
polyphenols activate Nrf2.
From a metabolic perspective, limiting inflammation is also ideal, thus overlap-
ping benefits are observed from the anti-inflammatory effects described when 
considering metabolic dysfunction. Limitation of NF-κβ activity provides a protec-
tive effect against the inflammatory state caused by obesity. Polyphenols have also 
been shown to improve insulin sensitivity and metabolic regulation by modifying 
the level of acetyl-coA directly. Levels of acetyl-coA strongly determine the activ-
ity of acetyl-coA carboxylase which can regulate metabolic flux. Polyphenols also 
affect the expression of acetyl-coA carboxylase by altering the activity of histone 
acetyltransferase (HAT) enzymes. These enzymes along with histone deacetylase 
enzymes (HDAC) appear sensitive to polyphenol interaction and are responsible 
for epigenetic reprogramming that alter gene expression level. Modifications at the 
epigenetic level offer re-regulation of metabolism.
A role in cancer prevention and adjective therapy also emerges as studies show 
that epigenetic modifications by polyphenols can limit expression of tumor growth 
proteins while protecting cells from oxidative damage by traditional therapies. 
Much of this effect is also due to the limited activity of NF-κβ and activation of Nrf2 
that was described previously. Limiting inflammatory proteins while also protect-
ing against oxidative damage reduces the risk of DNA damage that could develop 
into cancer. In addition to the effects on HATs and HDACs, polyphenols have also 
been shown to affect DNA methyltransferase (DNMT) activity. These enzymes, 
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responsible for methylation and demethylation of DNA, are inhibited by polyphe-
nols in general and can limit the methylation level at a gene promoter, thus allowing 
its expression. One such study showed higher levels of methylation at the BRCA1 
gene promoter resulting in decreased expression and shorter interval before disease 
return. Treatment with catechin polyphenols limited the methylation of BRCA1 
and increased disease free intervals. Early studies of adjunctive therapies with 
polyphenols demonstrate a potential for polyphenols mediated transition metal 
increased oxidative damage to the cancer cells that can overcome the cancerous 
cells’ increased ability to handle oxidative stress and therefore achieve cell death. 
There is still much to be studied regarding this pro-oxidant effect of transition 
metal interaction with polyphenols, but the potential to target cancer cells more 
directly is encouraging.
A summary of the potential for polyphenols to be used to reduce inflammatory 
markers, particularly the one associated with a most negative outcome, are sup-
pressed with the addition of certain polyphenols. An overlap exists between the 
suppression of inflammatory factors and the potential for metabolic re-regulation. 
In addition to the effects on metabolic regulation achieved by decreasing inflamma-
tion, polyphenols also offer improved support of metabolic regulation via metabolic 
enzyme control and transcription factor mediation. Epigenetic effects cross over 
between metabolic control and anti-cancer potential, demonstrating again the 
potential for multi-targeted benefits.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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